Skip to main content

Table 5 Comparison between patients with normal mood in the CM group (n = 14) and the control group (n = 50) at baseline

From: Preventive treatment can reverse cognitive impairment in chronic migraine

 

CM NMA

(n = 14)

\(\overline{\mathbf x}\;(\mathbf S\mathbf D)\)  

Control group

(n = 50)

\(\overline{\mathbf x}\;(\mathbf S\mathbf D)\)  

P Value

Cognitive measures

 ROCF-c

3261 (3.1)

33.1 (2.96)

0.504

 ROCF-m

18.46 (4.01)

23.49 (5.45)

0.001

 TMT-A

45.89 (20.89)

42.61 (39.62)

0.104

 TMT-B

92.97 (44.85)

82.37 (58.95)

0.111

Emotional state

 HADS—A

5.64 (2.53)

4.77 (2.42)

0.165

 HADS—D

3.5 (1.7)

2.02 (1.77)

0.004

 BDI-II

5.64 (1.6)

3.71 (3.3)

0.040

Quality of life

 SF-36 PF

80 (14.14)

90.85 (19.39)

0.000

 SF-36 RP

35.71 (38.87)

86.22 (31.5)

0.000

 SF-36 BP

35.36 (18.93)

92.62 (99.79)

0.000

 SF-36 GH

55.36 (12.16)

73.05 (17.32)

0.001

 SF-36 VT

48.04 (17.02)

67.34 (17.57)

0.001

 SF-36 SF

74.11 (24.25)

89.02 (16.34)

0.023

 SF- 36 RE

59.55 (47.47)

91.07 (22.4)

0.006

 SF-36 MH

66 (19.3)

78.46 (12.41)

0.022

 PSQI-GS

7.08 (3.68)

4.98 (3.31)

0.026

  1. NMA No mood alterations ROCF-c Rey-Osterrieth Complex Figure test, copy task, ROCF-m ROCF, memory task, TMT-A Trail Making Test A, attention test, TMT-B Trail Making Test B, divided attention test, HADS-A Hospital Anxiety and Depression Scale, anxiety subscale, HADS-D Hospital Anxiety and Depression Scale, depression subscale, BDI-II Beck Depression Inventory II, SF-36 PF 36-item Short Form Health Survey, physical functioning, SF-36 RP role-physical, SF-36 BP bodily pain, SF-36 GH general health, SF-36 VT vitality, SF-36 SF social functioning, SF-36 RE role-emotional, SF-36 MH mental health, PSQI-GS Pittsburgh Sleep Quality Index, global score